Initial Public Offering (Details) - USD ($) |
1 Months Ended | 3 Months Ended | |
|---|---|---|---|
Sep. 30, 2021 |
Sep. 17, 2021 |
Mar. 31, 2022 |
|
| Initial Public Offering (Details) [Line Items] | |||
| Offering costs | $ 3,445,200 | $ 3,445,200 | |
| Underwriting fees | 2,137,800 | 2,137,800 | |
| Underwriting expenses | $ 1,307,400 | $ 1,307,400 | |
| Public warrant, description | Each Unit consisted of one share of common stock and one Public Warrant. Each redeemable Public Warrant entitles the holder to purchase one share of common stock at a price of $6.25 per share, will be exercisable upon issuance and will expire five years from issuance | ||
| Additional shares (in Shares) | 720,000 | ||
| Warrant purchase (in Shares) | 720,000 | ||
| Common stock price per share (in Dollars per share) | $ 5 | ||
| Initial Public Offering [Member] | |||
| Initial Public Offering (Details) [Line Items] | |||
| Number of sold units (in Shares) | 4,800,000 | ||
| Price per unit (in Dollars per share) | $ 5 | ||
| Number of sold units, value | $ 24,000,000 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Description of expense or revenue offset related to the warrants or rights. No definition available.
|
| X | ||||||||||
- Definition The number of warrants or rights which entitle the entity to receive future services in exchange for the unvested, forfeitable warrants or rights. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Number of additional shares authorized for issuance under share-based payment arrangement. No definition available.
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Details
|